Encouraged by these data, we conducted a subcutaneously implanted tumor model by injecting these cells into BALB/c mice, which showed that SETDB1 could significantly promote tumor progression in MCT1 WT CT26 cells, but not in MCT1 K467R CT26 cells (Figure 6g–i). Here, SETDB1 is linked to neoplasm.